Eastlund T
American Red Cross, North Central Blood Services, St. Paul, Minnesota, USA.
Transfusion. 1998 Oct;38(10):975-88. doi: 10.1046/j.1537-2995.1998.381098440863.x.
In general, one might expect that ABO incompatibility of donor and recipient would be important to some degree if viability of the transplanted allograft is important for graft incorporation and function. This is true for some recipients of organs. However, ABO incompatibility appears to play a minor role, if any, in the clinical success of viable cornea and viable skin allografts. Even though A and B antigens may be present on the transplanted tissue, other factors that can contribute include the strength of the immune response, the avidity of the antibody, and the dose of the antigen presented, which may vary from donor to donor. Although A and B antigens are present on endothelium, the use of ABO-incompatible heart valves is successful, as they carry out their mechanical function by using the strength of the connective tissue rather than the viability of the donor endothelium. The presence, immunogenicity, and significance of A and B antigens in human vessel transplants have not been well studied. With the more commonly transplanted tissue, such as bone and tendon, posttransplant success does not depend on cellular viability or ABO compatibility.
一般来说,如果移植的同种异体移植物的存活对于移植物的整合和功能很重要,那么人们可能会认为供体和受体的ABO血型不相容在某种程度上是重要的。对于一些器官接受者来说确实如此。然而,ABO血型不相容在存活角膜和存活皮肤同种异体移植的临床成功中似乎只起很小的作用,甚至可能不起作用。即使移植组织上可能存在A和B抗原,但其他可能起作用的因素包括免疫反应的强度、抗体的亲和力以及所呈现抗原的剂量,而这些因素在不同供体之间可能会有所不同。虽然A和B抗原存在于内皮细胞上,但使用ABO血型不相容的心脏瓣膜是成功的,因为它们通过利用结缔组织的强度来发挥机械功能,而不是依赖供体内皮细胞的存活。A和B抗原在人体血管移植中的存在、免疫原性和重要性尚未得到充分研究。对于更常见的移植组织,如骨骼和肌腱,移植后的成功并不取决于细胞的存活或ABO血型相容性。